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Abstract
The phytoestrogens genistein, daidzein and the daidzein
metabolite equol have been shown previously to possess
oestrogen agonist activity. However, following consumption
of soya diets, they are found in the body not only as aglycones
but also as metabolites conjugated at their 40- and 7-hydroxyl
groups with sulphate. This paper describes the effects of
monosulphation on the oestrogen agonist properties of these
three phytoestrogens in MCF-7 human breast cancer cells in
terms of their relative ability to compete with [
3H]oestradiol
for binding to oestrogen receptor (ER), to induce a stably
transfected oestrogen-responsive reporter gene (ERE-CAT)
and to stimulate cell growth. In no case did sulphation abolish
activity. The 40-sulphation of genistein reduced oestrogen
agonist activity to a small extent in whole-cell assays but
increasedtherelativebindingafﬁnitytoER.The7-sulphation
of genistein, and also of equol, reduced oestrogen agonist
activity substantially in all assays. By contrast, the position of
monosulphation of daidzein acted in an opposing manner on
oestrogen agonist activity. Sulphation at the 40-position of
daidzein resulted in a modest reduction in oestrogen agonist
activity but sulphation of daidzein at the 7-position resultedin
an increase in oestrogen agonist activity. Molecular modelling
and docking studies suggested that the inverse effects of
sulphation could be explained by the binding of daidzein into
the ligand-binding domain of the ER in the opposite
orientation compared with genistein and equol. This is the
ﬁrst report of sulphation enhancing activity of an isoﬂavone
and inverse effects of sulphation between individual
phytoestrogens.
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Introduction
Many compounds produced naturally by plants (termed
phytoestrogens) have been shown in vivo to modulate the
actions of endogenous oestrogens giving rise to endocrine
disruption and in vitro to be able to mimic oestrogen action
with resulting agonist and/or antagonist actions (Woods
2003). Although several mechanisms are now recognised, a
major basisfor their actionoccurs through their abilityto bind
to the oestrogen receptors (ERa and ERb) and thus to
inﬂuence the subsequent ligand-activated functions of these
transcription factors on patterns of gene expression (Woods
2003). Of the many phytoestrogens, the isoﬂavones genistein
and daidzein can be consumed in relatively large amounts in
soya bean-rich diets such as those found in Eastern
populations where there are relatively low levels of
hormone-dependent cancers and menopausal symptoms,
and interest has increased therefore in their use as dietary
supplements with measurable health beneﬁts (Adlercreutz &
Mazur 1997, Woods 2003).
Genistein and daidzein have been shown previously to
possess oestrogen agonist activity in human breast cancer
cells in vitro (Wang & Kurzer 1997, Hsieh et al. 1998,
Makela et al. 1999, Dampier et al. 2001, Maggiolini et al.
2001, Chen et al. 2003, Woods 2003, Matsumura et al. 2005,
Hwang et al. 2006). The isoﬂavan equol is a metabolite
produced by the reduction of daidzein by gut micro-
organisms, albeit to varying extents in different individuals
(Woods 2003), and equol has also been shown to have
oestrogenic activity in human breast cancer cells (Welshons
et al. 1987, Matsumura et al. 2005). Although genistein and
daidzein can be detected in the plasma and urine of humans
who consume soya foods, the majority of these isoﬂavones
circulate and are excreted in urine as mono- and disulphates,
mono- and diglucuronides and sulphoglucuronides through
conjugation at their 40- and 7-hydroxyl groups (Adlercreutz
et al. 1995, Shelnutt et al. 2000, 2002, Thomas et al. 2001,
Zhang et al. 2003). Glucuronides are the most abundant
conjugates (Zhang et al. 2003), but sulphates of genistein and
daidzein have been shown to make up a signiﬁcant proportion
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21 and 20% respectively (Zhang et al. 2003) and in a second
study of 8 and 23% respectively (Shelnutt et al. 2002), and
in urine of 24 and 23% respectively (Zhang et al. 2003).
In urine, site-speciﬁc studies have measured monosulphates as
13% of total daidzein with disulphates making up !0.1%
(Clarke et al. 2002).
At target tissues, overall activityof these phytoestrogenswill
depend not only on the enzymatic hydrolysis of the
conjugates back to the aglycones by tissue sulphatases and
b-glucuronidases (Shelnutt et al. 2002) but also on any
intrinsic oestrogenic activity of the conjugates themselves.
Human breast cancer cells are known to possess both
sulphotransferase and sulphatase activities, which additionally
can be inﬂuenced by the phytoestrogens themselves (Kirk
et al. 2001, Harris et al. 2004). However, little is known of the
intrinsic oestrogenic activity of the conjugates. Genistein
glucuronides have been reported to retain weak ER-binding
capability (Zhang et al. 1999) but the effect of sulphation
remains uncertain (Kinjo et al. 2004, Totta et al. 2005). We
report here on the varied ability of the monosulphates of
genistein, daidzein and equol to bind to cytosolic ER of
MCF-7 human breast cancer cells and to act on the whole
MCF-7 cells to regulate oestrogen-responsive gene
expression and to increase oestrogen-dependent cell growth.
The inverse effect of sulphation on oestrogen agonist activity
of genistein and equol compared with daidzein led us to carry
out molecular modelling and docking using the program suite
GRID/GLUE (Molecular Discovery Ltd, Ponte San
Giovanni, Italy) to investigate the possible binding modes in
which these ligands can interact with the ligand-binding
domain (LBD) of human ERa and ERb.
Materials and Methods
Chemicals
Genistein (98% purity) was purchased from Sigma. Daidzein
(98% purity), dl-equol (97–98% purity) and genistein-7-
sulphate were purchased from Plantech (Reading, Berkshire,
England). 17b-Oestradiol was purchased from Steraloids
(Croydon, England). Daidzein-7-sulphate (95% purity) and
daidzein-40-sulphate (96% purity) were synthesised as
described previously (Fairley et al. 2003). Genistein-40-
sulphate and equol-7-sulphate were synthesised by analogous
methods.
All compounds were made as stock solutions in ethanol or
dimethyl sulphoxide (DMSO) and diluted into culture
medium. Stock solutions of genistein, genistein-40-sulphate,
equol and equol-7-sulphate were prepared at 10
K2 Mi n
ethanol. Stock solutions of daidzein and sulphates were
prepared at 10
K3 M in ethanol. Stock solutions of genistein-
7-sulphate were prepared at 10
K2 M in DMSO.
For genistein and equol, cell culture experiments using
10
K5 M concentrations were performed by diluting the stock
10
K2 M solutions at 1 in 1000 (v/v) in culture medium, and
controls were performed with equivalent concentrations
of ethanol or DMSO. For concentrations of 10
K6 M and
below, the stock solutions were serially diluted such that the
dilutionintoculturemediumwasalways1in10 000(v/v),and
controls were performed with equivalent concentrations of
ethanol or DMSO.
For daidzein and sulphates, the cell culture experiments
using 10
K6 M concentrations were performed by diluting
the stock 10
K3 M solutions at 1 in 1000 (v/v) in culture
medium, and controls were performed with equivalent
concentrations of ethanol. For concentrations of 10
K7 M
and below, the stock solutions were serially diluted such that
the dilution into culture medium was always 1 in 10 000
(v/v), and controls were performed with equivalent
concentrations of ethanol.
Culture of stock cells
MCF-7 McGrath human breast cancer cells were kindly
provided by C K Osborne at passage number 390
(Osborne et al. 1987). This cell line is dependent on
oestrogen for growth as described previously (Darbre &
Daly 1989). Stock MCF-7 cells were grown as monolayer
cultures in Dulbecco’s modiﬁed Eagle’s medium (Invi-
trogen) supplemented with 5% (v/v) fetal calf serum (FCS;
Invitrogen), 10 mg/ml insulin (Sigma) and 10
K8 M1 7 b-
oestradiol in a humidiﬁed atmosphere of 10% carbon
dioxide in air at 37 8C. The cell stocks were subcultured at
weekly intervals by suspension with 0.06% trypsin/0.02%
EDTA (pH 7.3).
Competitive binding assay to ER of MCF-7 cytosol
MCF-7 human breast cancer cells were grown as monolayer
cultures in phenol red-free RPMI 1640 medium (Invitrogen)
with 5% dextran-charcoal-stripped FCS (DCFCS; Darbre
et al. 1983) for a minimum of 3 days to deplete steroid
hormone levels in the cells. The cells were then harvested,
pelleted and homogenised in eight volumes of buffer (10 mM
Tris–HCl, 1 mM EDTA, 2 mM dithiothreitol, 10% (v/v)
glycerol, 0. 5 M NaCl, pH 7.4) at 4 8C. Homogenates were
centrifuged at 105 000 g for 1 h at 4 8C, and the resulting
supernatant was stored in aliquots at K70 8C. Competitive
binding assays were performed on the cytosol using the
dextran-coated charcoal method as described previously
(Green & Leake 1987). Competition was assayed between
the binding of [2,4,6,7-
3H]oestradiol (Amersham Inter-
national) at 4!10
K10 M and 1- to 100 000-fold molar excess
of unlabelled compounds.
Competitive binding assay to recombinant ERa
Full-length human recombinant ERa (Invitrogen) was
diluted 1:2500 in buffer (10 mM Tris–HCl, 1 mM EDTA,
2 mM dithiothreitol, 10% (v/v) glycerol, 0.5 M NaCl, pH
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binding assays were performed in 96-well polystyrene plates
for 18 h at 4 8C between the binding of [2,4,6,7-
3H]oestra-
diol (GE Healthcare: Amersham International) at 0.8n M
and 1- to 1 000 000-fold molar excess of unlabelled
phytoestrogen using 0.8 nM ER protein. Receptor–ligand
complexes were separated from free ligand using the
hydroxylapatite method as described previously (Green &
Leake 1987).
Assay of stably transfected ERE-CATreporter gene in MCF-7
cells
The ERE-CAT (oestrogen response element–chloramphe-
nicol acetyl transferase) vector consisted of the ERE of the
vitellogenin A2 gene from K331 to K295 bp cloned into the
pBLCAT2 vector (Luckow & Schutz 1987) upstream of
the thymidine kinase promoter. A clonal line of MCF-7 cells
stablytransfectedwith this vector was previouslycharacterised
and the assay was carried out exactly as published previously
(Byford et al. 2002). P values were calculated using a two-
tailed student t-test, two-sample assuming unequal variance,
within the MS Excel 2000 software package.
Cell proliferation experiments
Thecellswereaddedtotherequiredvolumeofphenolred-free
RPMI1640mediumcontaining5%DCFCSataconcentration
of about 0.2!10
5 cells/ml and plated in monolayer in 0.5m l
aliquots into 24-well plastic tissue culture dishes (Nunc,
Roskilde, Denmark). After 24 h, the medium was changed to
phenol red-free RPMI 1640 medium supplemented with 5%
DCFCSwithorwithoutsupplementsof17b-oestradioland/or
phytoestrogen. The culture medium was changed routinely
every 3–4 days in all experiments. The cell counts were
performedbycountingreleasednucleionamodelZBICoulter
Counter, as described previously (Daly & Darbre 1990).
Doubling time of the cells was calculated as a function of the
slope of the linear plot of log10 (cell number) against time.
Doubling time was calculated as log10 2/slope. P values were
calculated using a two-tailed student t-test, two-sample
assumingunequalvariance,withintheMSExcel2000software
package.
Molecular modelling and docking of ligand binding to the LBD of
human ER
The crystal structures of 1A52, an oestradiol-ERa complex
(Tanenbaum et al. 1998) and 1!7R, a genistein-ERa
complex (Manas et al. 2004) were obtained from the Protein
Data Bank (http://www.ebi.ac.uk). The oestrogen ligand
was removed from the coordinate ﬁle of 1A52 and the
resulting protein was subjected to molecular mechanics and
energy minimisation using the consistent valence force ﬁeld
(CVFF) in InsightII (Cerius2 Modeling Environment,
Release 4.8, Accelrys Inc., San Diego, CA, USA) as the
starting structure for the docking studies. The structures of
genistein, daidzein and equol were built using the
BUILDER module in InsightII and a conformational
minimisation was performed for each modelled ligand
using the software Mizer (Molecular Discovery Ltd) to
obtain the lowest energy conformer for the docking studies.
GRID was used to calculate the molecular interaction ﬁelds
(MIFs) within the active site of the protein, according to
hydrophobic, hydrogen-bond donor/acceptor and electro-
static interaction capabilities and geometries (Goodford
1985, Pastor et al. 1997, Carosati et al. 2004). Eight default
GRID probes (H, OH2, DRY, N1C, N1, N:Z,O K and
OH) were used for the MIF calculation. GLUE, a GRID-
based docking program, was used to dock each ligand into
the LBD of human ERa for subsequent analysis (Sciabola et
al. 2005). GLUE calculates the interaction energy between
an entire ligand and a protein-binding site, proposes several
docking solutions, and ranks these by the values of the
energy scoring function. The docking solution with the
lowest and most favourable energy was chosen to compare
the docking results of the different ligands in the protein-
binding pocket. GLUE generates possible interactions
between the ligand and the active site of the protein
molecule by ﬁtting the maps (or MIFs) generated by GRID
for each probe, which mimics the functional groups on the
ligands of interest, to the potential ligand-binding site.
GLUE then positions the ﬂexible hydrophobic and polar
atoms of the ligands by generating several conformations
(poses) over their corresponding energy maps. The most
favourable modes of binding are then optimised within the
active site of the protein by calculating successive torsion and
translation energies driven by the protein–ligand interaction
energy as computed by the GRID force ﬁeld. Thus, it is
expected that the resulting docked pose and its associated
energy represents a realistic and potentially biologically
relevant bound conformation. Indeed, to test the reliability
of the docking as performed by GLUE, we ﬁrst docked the
crystal structure of genistein, extracted from 1!7R (an ERa
– genistein co-crystallised complex), into 1A52 (with the
oestrogen ligand removed). The default GRID/GLUE
parameters were used for the MIF calculation and docking
procedure. For binding optimisation, 1000 iterations were
used. We next applied the same GRID/GLUE parameters to
dock the modelled structures (using InsightII) of genistein,
daidzein and equol into the active site of 1A52. The docking
results were visualised using PyMOL (DeLano Scientiﬁc
LLC, San Francisco, CA, USA), the hydrogen bond and van
der Waals interactions were calculated using the program
CONTACT available in the CCP4 suite (CCP4, 2003) and
the root mean square deviation (RMSD) was calculated
using the least-squares ﬁtting procedure provided in the
program ‘O’ version 9.0.7 ( Jones et al. 1990). The potential
hydrogen bonds were assigned if the distance between two
electronegative atoms was !3.3A ˚. The van der Waals
interactions were assigned where the separation between
non-bonded hydrogen atoms was !4A ˚.
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The program GRID was used to calculate the energies of
interaction between a sulphoxide functional group (OS
probe: oxygen sulphoxide/sulphonate) and the LBD of
human ER. The box chosen for the GRID calculation was
such that it was centred over the ligand-binding site of the
LBD of ERa and ERb (using 1!7R and 1QKM
respectively, as the target structures). A 5 A ˚ clearance and
0.5A ˚ spacing were used for the GRID calculation. The
resulting MIF was visualised using GVIEW (Molecular
Discovery Ltd), as provided within the GRID program
(version 22a). An energy threshold of K5.0 kcal/mol was
chosen for ﬁnal visualisation using PyMOL.
Figure 1 Comparison of the chemical structures of 17b-oestradiol, genistein, genistein-40-sulphate,
genistein-7-sulphate, daidzein, daidzein-40-sulphate, daidzein-7-sulphate, equol and equol-7-sulphate.
Dotted arrows indicate the orientation of binding of 17b-oestradiol (Brzozowski et al. 1997) and genistein
(Manas et al. 2004) into the LBD of ERa and ERb respectively, as determined by X-ray crystallography.
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Experimental strategy
The chemical structures of the phytoestrogens and their
monosulphates included in this study are given in Fig. 1.
Oestrogen agonist activity was assessed for a range of
concentrations for each phytoestrogen using a variety of
validated assays based in MCF-7 human breast cancer cells
(Byford et al. 2002, Matsumura et al. 2005): 1) ligand ability to
bind to ER from MCF-7 cell lysates in a competitive binding
assay, 2) ligand ability to regulate expression of a stably
transfected oestrogen-responsive reporter gene (ERE-CAT)
in MCF-7 cells and 3) ligand ability to regulate the
proliferation of oestrogen-dependent MCF-7 cells.
Ligand binding to ER of MCF-7 cell lysates
Since the ﬁrst step in the action of anyoestrogenic compound
involves the binding of ligand to an intracellular receptor
(Oettel & Schillinger 1999), experiments began by determin-
ingtheeffectofsulphationonbindingofthephytoestrogensto
ER of MCF-7 cell cytosol. In a single-point competitive
binding assay, ERs from MCF-7 human breast cancer cells
were incubated at 4 8Cf o r1 8 hw i t h4 !10
K10 M
[2,4,6,7-
3H]oestradiol and the extent of inhibition of binding
was determined with increasing concentrations of unlabelled
monosulphated and non-sulphated forms of genistein,
daidzein and equol. Figure 2A shows that genistein-40-
sulphate was more effective at inhibiting [
3H]oestradiol
binding than genistein. By contrast, sulphation of genistein
at the 7-position resulted in a much reduced inhibition of
[
3H]oestradiol binding and inhibition was only 19% even
at 100 000-fold molar excess (Fig. 2A). Figure 2B shows that
daidzein-7-sulphate was more effective at inhibiting [
3H]oes-
tradiol binding than daidzein. Sulphation of daidzein on the
40-position, however, did not alter the ability of the
phytoestrogen to displace [
3H]oestradiol to any signiﬁcant
extent compared with the aglycone. By contrast, Fig. 2C
shows that sulphation of equol on the 7-conjugation site
reduced the ability of the ligand to displace [
3H]oestradiol.
Control experiments showed that [
3H]oestradiol binding
was inhibited by 96% by 10-fold molar excess and by 100% by
100-fold molar excess of diethylstilboestrol. Previous work
using the same assay in our laboratory has shown that the
glucocorticoid, dexamethasone, has no effect on [
3H]oes-
tradiol binding at concentrations of up to 100 000-fold molar
excess (Byford et al. 2002).
Ligand ability to increase the expression of ERE-CATreporter
gene in MCF-7 cells
The effect of sulphation on phytoestrogen regulation of
oestrogen-responsive gene expression was tested using a stably
transfected oestrogen-sensitive reporter gene (ERE-CAT) in
MCF-7 human breast cancer cells (Byford et al. 2002,
Matsumura et al. 2005). Using a clonal line of MCF-7 cells
containingastablyintegratedERE-CATreportergene,thecells
were deprived of steroid for 7 days and then CAT gene
expression was assayed after 24 hours of treatment with 17b-
oestradiol or phytoestrogen. Results are shown in Fig. 3 as a %
of the induction with 10
K8 M1 7 b-oestradiol. For all the
three phytoestrogens, sulphation reduced the ability of the
compound to increase CAT activity but some activity was
retained in every case, albeit at higher concentrations.
Genistein-40-sulphate increased CATactivity to a signiﬁcantly
lower extent than genistein at 10
K7 M( 3 8 .6G3.0% vs 70.1G
2.2%; PZ0.037; Fig. 3A). Genistein-7-sulphate increased
CAT activity only at concentrations of 10
K5 M and above
(Fig. 3A). Daidzein-7-sulphate increased CAT activity to a
signiﬁcantly lesser extent than daidzein at 10
K7 M( 7 .7G3.6%
vs 35.6G1.1%; PZ0.097; Fig. 3B). Daidzein-40-sulphate
increased CAT activity to a signiﬁcantly lower extent than
daidzeinat10
K7 M(2.8G2.8%vs35.6G1.1%;PZ0.037)and
at 10
K6 M( 1 7 .2G1.7% vs 82.3G2.7%; PZ0.018) (Fig. 3B).
Equol-7-sulphateincreasedCATactivitytoasigniﬁcantlylower
extent than equol at 10
K7 M( 1 3 .2G2.4% vs 54.0G1.7%;
Figure 2 Competitive binding of monosulphated and non-sulphated forms of (A) genistein, (B) daidzein and (C) equol to ER from
MCF-7 human breast cancer cells. In single-point competitive binding assays, 4!10
K10 M [2,4,6,7-
3H]oestradiol was incubated
with cytosol plus the stated molar excess of unlabelled genistein (solid square, solid line), genistein-40-sulphate (open square, dotted
line), genistein-7-sulphate (open diamond, dotted line), daidzein (solid circle, solid line), daidzein-40-sulphate (open circle, dotted
line), daidzein-7-sulphate (open star, dotted line), equol (solid triangle, solid line) and equol-7-sulphate (open triangle, dotted line).
Error bars represent the meanGS.E.M. of triplicate assays.
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K6 M (12.8G1.8% vs 88.8G1.4%;
P!0.001) (Fig. 3C). However, while 10
K5 M concentrations
ofequolresultedinareducedinductionofCATactivity(72.5G
2.1%),reductionininductionofCATactivitywasnotobserved
with 10
K5 M equol-7-sulphate (24.2G2.4%) (Fig. 3C).
Ligand ability to stimulate proliferation of MCF-7 human breast
cancer cells
MCF-7 human breast cancercells aredependent on oestrogen
for their proliferation in monolayer culture (Darbre & Daly
1989, Byford et al. 2002, Matsumura et al. 2005). Since these
growth assays were not set up as one single experiment and
plating densities varied, comparison was achieved by
expressing the results as the % number of doublings with
the phytoestrogen compared with the number of doublings
with 10
K8 M1 7 b-oestradiol in that same assay. The cell
growth assays showed that genistein, daidzein and equol could
increase proliferation of MCF-7 cells after 7 (Fig. 4) or
14 days (Fig. 5), although requiring varying concentrations.
Sulphation had varied effects on the ability of the
phytoestrogens to increase cell proliferation.
The growth of MCF-7 cells was increased by genistein after
7daysat10
K8 M(PZ0.021),10
K7 M(PZ0.005)and10
K6 M
(PZ0.001) (Fig. 4A) and after 14 days at 10
K8 M( PZ0.011),
10
K7 M( PZ0.006) and 10
K6 M( PZ0.006) (Fig. 5A). By
contrast, genistein-40-sulphate did not increase growth at
10
K8 M after 7 days (PZ0.258) (Fig. 4A) or 14 days
(PZ0.209) (Fig. 5A). The growth increase at 10
K7 Ma n d
10
K6 M genistein-40-sulphate was relatively less than with
genistein after both 7 days (Fig. 4A) and 14 days (Fig. 5A).
Genistein-7-sulphate increased growth only at concentrations
of 10
K5 M and above after either 7 days (Fig. 4A) or 14 days
(Fig.5A).ThegrowthofMCF-7cellswasincreasedbydaidzein
after 7 days at 10
K7 M( PZ0.052) and 10
K6 M( PZ0.006)
(Fig. 4B) and after 14 days at 10
K7 M( PZ0.008) and 10
K6 M
(PZ0.028) (Fig. 5B). The growth increase observed with
daidzein-7-sulphate was very similar to that with daidzein after
7days (Fig. 4B) or 14 days (Fig. 5B). However, daidzein-40-
sulphate was only able to increase growth at 10
K6 Ma f t e r
Figure 3 Regulationbymonosulphatedandnon-sulphatedformsof(A)genistein,(B)daidzeinand(C)equolofCATgeneexpression
fromastablytransfectedERE-CATgeneinMCF-7humanbreastcancercells.ThecellsweregrowninRPMI1640medium/5%DCFCS
for7days,andtheninthesamemediumforafurther24 hwithgenistein(solidsquare,solidline),genistein-40-sulphate(opensquare,
dotted line), genistein-7-sulphate (open diamond, dotted line), daidzein (solid circle, solid line), daidzein-40-sulphate (open circle,
dottedline),daidzein-7-sulphate(openstar,dottedline),equol(solidtriangle,solidline)andequol-7-sulphate(opentriangle,dotted
line) at the molar concentrations indicated. The results are presented graphically as the % of the induction with 10
K8 M
17b-oestradiol. Bars represent the meanGS.E.M. of triplicate assays both with 17b-oestradiol and with phytoestrogen.
Figure 4 Effects of monosulphated and non-sulphated forms of (A) genistein, (B) daidzein and (C) equol on the proliferation of MCF-7
human breast cancer cells in monolayerculture. The cells were grown for 7 days in phenol red-free RPMI 1640 medium/5% DCFCS with
no further addition (given at zero molar concentration) or with genistein (solid square, solid line), genistein-40-sulphate (open square,
dottedline),genistein-7-sulphate(open diamond,dottedline),daidzein(solid circle, solid line),daidzein-40-sulphate(opencircle,dotted
line), daidzein-7-sulphate (open star, dotted line), equol (solid triangle, solid line) and equol-7-sulphate (open triangle, dotted line) at the
molar concentrations indicated. The results are presented graphically as the % number of doublings with the phytoestrogen compared
with the number of doublings with 10
K8 M1 7 b-oestradiol in that same assay. Error bars are the standard error of all nine values from
triplicate dishes with 10
K8 M1 7 b-oestradiol and triplicate dishes with phytoestrogen.
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increased to a small extent by equol at 10
K8 M after 14 days
(PZ0.029),buttoagreaterextentatconcentrationsof10
K7 M
and above after both 7 days (Fig. 4C) and 14 days (Fig. 5C).
Equol-7-sulphatewas unable to increase the growth ofMCF-7
cellsexceptveryweaklyafter14daysat10
K5 Mconcentrations
(PZ0.008) (Fig. 5C).
Ligand binding to recombinant ERa
SinceMCF-7cellspossesssulphataseactivity(Harrisetal.2004),
it is possible that observed levels of activity with the sulphated
compounds, which are equivalent to or below that of the
aglycone could result from enzymatic desulphation within the
cells. High-speed centrifugation of the MCF-7 cell lysates for
receptor-binding assays would remove microsomes, but it
cannot be entirely excluded that some sulphatase activity
remained in the cell cytosol. Therefore, further competitive
binding assays were carried out using puriﬁed recombinant
human ERa (PanVera) where nosulphatase activitycould have
been present. Our MCF-7 cells contain mostly ERa in a ratio
of ERa:ERb of 19:1 (Shaw et al. 2006). Figure 6 shows that all
the phytoestrogen sulphates could displace the binding of
[
3H]oestradiol to the recombinant human ERa with similar
overall concentration dependence to that observed using the
MCF-7 cell lysates in Fig. 2, except that daidzein displaced
[
3H]oestradiolatlowerconcentrationsinthisassayanddaidzein-
40-sulphate was notably weaker in binding than the aglycone.
Assessment of relative overall oestrogenic potency
The relative oestrogenic potency of each compound was
assessed by calculating for the ER-binding assays, the molar
excess needed to displace 50% of the [
3H]oestradiol binding to
the ER (Figs 2 and 6), and for the whole-cell assays, the molar
concentration needed to achieve a response equivalent to 50%
of that with oestradiol (Figs 3–5). Data were assembled into
Table 1 in the rankorder of potency for each assay. Where 50%
Figure 5 Effects of monosulphated and non-sulphated forms of (A) genistein, (B) daidzein and (C) equol on the proliferation of MCF-7
human breast cancer cells in monolayer culture. The cells were grown for 14 days in phenol red-free RPMI 1640 medium/5% DCFCS
with no further addition (given at zero molar concentration) or with genistein (solid square, solid line), genistein-40-sulphate (open
square, dotted line), genistein-7-sulphate (open diamond, dotted line), daidzein (solid circle, solid line), daidzein-40-sulphate (open
circle, dotted line), daidzein-7-sulphate (open star, dotted line), equol (solid triangle, solid line) and equol-7-sulphate (open triangle,
dotted line) at the molar concentrations indicated. The results are presented graphically as the % number of doublings with the
phytoestrogen compared with the number of doublings with 10
K8 M1 7 b-oestradiol in that same assay. Error bars are the standard error
of all nine values from triplicate dishes with 10
K8 M1 7 b-oestradiol and triplicate dishes with phytoestrogen.
Figure 6 Competitive binding of monosulphated and non-sulphated forms of (A) genistein, (B) daidzein and (C) equol to recombinant
human ERa (Invitrogen). In single-point competitive binding assays, 0.8 nM [2,4,6,7-
3H]oestradiol was incubated with 0.8n M
recombinant receptor protein plus the stated molar excess of unlabelled genistein (solid square, solid line), genistein-40-sulphate (open
square, dotted line), genistein-7-sulphate (open diamond, dotted line), daidzein (solid circle, solid line), daidzein-40-sulphate (open
circle, dotted line), daidzein-7-sulphate (open star, dotted line), equol (solid triangle, solid line) and equol-7-sulphate (open triangle,
dotted line). Error bars represent the meanGS.E.M. of triplicate assays.
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www.endocrinology-journals.org Journal of Endocrinology (2008) 197, 503–515Table 1 (A) Descending rank order of the relative oestrogen agonist activities of genistein, daidzein, equol and their monosulphates for each of the ﬁve assays given in Figs 2–6. The
relative oestrogenic potency is shown in terms of the molar excess for displacement of 50% of the [
3H]oestradiol binding to ER and molar concentration needed to achieve 50% of the
response with oestradiol. Compounds are listed in descending order of activity for each assay. Where 50% responses were not achieved, the maximal observed responses are given in
brackets and rank order was based on consideration of all the data points. (B) Sum totals of rank placings in all ﬁve assays for each compound, with compounds listed in descending
order of relative activity
(A) Assay
Rank order of oestrogenic potency
Rank 1 Rank 2 Rank 3 Rank 4 Rank 5 Rank 6 Rank 7 Rank 8
Binding to ER/MCF-7cytosol
(molar excess to achieve
50% inhibition of [
3H]
oestradiol binding)
G40S 650! Genistein 1000! Equol 3700! D7S 5000! D40S (44% at
10 000!)
Daidzein (40%
at 10 000!)
Eq7S (2% at
10 000!)
G7S (19% at
100 000!)
Binding to recombinant ERa
(molar excess to achieve
50% inhibition of [
3H]
oestradiol binding)
G40S 400! Equol 550! Genistein
1700!
Daidzein
2500!
D7S 4000! G7S 4500! D40S1 00 0 0 ! Eq7S (67% at
100 000!)
Induction of reporter gene
(molar concentration for
50% response with
10
K8 M oestradiol)
Genistein 5!
10
K8 M
Equol 8!10
K8 MG 4 0S2 !
10
K7 M
Daidzein 2!
10
K7 M
D7S 5!10
K7 MD 4 0S( 1 7 %a t
10
K6 M)
Eq7S (24% at
10
K5 M)
G7S (11% at
10
K5 M)
Cell growth after 7 days
(molar concentration for
50% response with 10
-8 M
oestradiol)
Equol 2!10
K9 M Genistein 7!
10
K9 M
D7S 2!
10
K8 M
G40S3 !
10
K8 M
Daidzein 5!
10
K8 M
G7S 2!10
K6 MD 4 0S (23% at
10
K7 M)
Eq7S 10
K5 M
Cell growth after 14 days
(molar concentration for
50% response with
10
K8 M oestradiol)
Genistein 4!
10
K9 M
Equol 10
K8 M D7S 5!
10
K8 M
G40S9 !
10
K8 M
Daidzein
10
K7 M
D40S7 !
10
K7 M
G7S 8!10
K6 M Eq7S (36% at
10
K5 M)
(B) Compound
Total sum of placings in each rank order
Rank 1 Rank 2 Rank 3 Rank 4 Rank 5 Rank 6 Rank 7 Rank 8
Genistein 2 2 1
Equol 1 3 1
Genistein-40-sulphate (G40S) 2 1 2
Daidzein-7-sulphate (D7S) 2 1 2
Daidzein 221
Daidzein-40-sulphate (D40S) 122
Genistein-7-sulphate (G7S) 212
Equol-7-sulphate (Eq7S) 23
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are shown in brackets and the rank order was obtained by
considerationofallthedatapoints.Table1showsthesumtotals
of rank places in all the ﬁve assays for each compound and the
compounds are listed in descending order of potency. In line
with previously published work (Matsumura et al. 2005),
genistein and equol showed greater oestrogenic activity than
daidzein. Genistein and equol were in the top three placings in
therankorderforeveryassay,whereasdaidzeinhadconsiderably
lower placings (Table 1). 7-Sulphation reduced substantially
the oestrogenic activity of genistein and equol, whereas the
7-sulphate of daidzein had much higher activity than the
aglycone.The40-sulphationincreasedtheactivityofgenisteinin
both the ER-binding assays. Although the 40-sulphation
of genistein reduced activity in the whole-cell assays, the 4-
-sulphate still retained substantial activity in marked contrast to
the 7-sulphate. The 40-sulphation of daidzein resulted in a
moderate reduction in oestrogenic activity.
Binding mode and sulphation
Molecular modellinganddockingstudieswerecarriedoutinan
attempt to understand the inverse effect of sulphation on the
oestrogen agonist action of daidzein compared with genistein
and equol. The conformationally minimised structures of
genistein, daidzein and equol were each docked into the
Figure 7 Molecular modelling and docking of (A) genistein, (B) equol and (C) daidzein into the crystal
structure of human LBD of ERa (1A52). The ligands are shown in bold outline with neighbouring amino
acid residues numbered according to 1A52. Hydrogen bonds (depicted by dashed lines) are shown
between the ligand and binding site residues with the bond lengths given in Angstroms (A ˚) for the
energetically favoured conformation. The docked energies for genistein, equol and daidzein were
K16.38, K17.60 and K14.91 kcal/mol respectively. The number of van der Waals interactions was 42,
48 and 41 for genistein, equol and daidzein respectively.
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werecomparedwiththatofgenistein.Fromthecrystalstructure
data (Manas et al. 2004), it is known that the 7-hydroxyl of
genistein forms a hydrogen bond with the amino acid residue
histidine 524 (His524) and the 40-hydroxyl of genistein
hydrogen bonds to glutamic acid 353 (Glu353) and arginine
394(Arg394)(Fig.7A).TovalidatetheGLUEdockingmethod,
bothgenisteinasextractedfromthe1!7Rcrystalstructureand
genistein as built using InsightII and minimised using Mizer
were docked into the ERa crystal structure 1A52. The
modelled genistein was found to correctly dock into the
ligand-binding site of 1A52, with a docked energy of
K16.38 kcal/mol, in a similar bound conformation and
orientation. The docking result for the modelled genistein
was within 1.2A ˚ to that of the crystallographic genistein
extracted from 1!7R with an overall RMSD value of 0.562
between the ca atoms (residues 306–544) of the two protein
structures. Docking of equol into the LBD of ERa gave a
docked energy value of K17.60 kcal/mol and an orientation,
which resembled that of genistein, with its 7-hydroxyl within
hydrogen-bondingdistanceofHis524andits40-hydroxylgroup
within hydrogen-bonding distance of Glu353 and Arg394
(Fig. 7B). By contrast, at its lowest and most favourable energy
conformation (K14.91 kcal/mol), daidzein docked into the
LBD of ERa in the opposite orientation from genistein and
equol, forming hydrogen bonds between its 7-hydroxyl and
Glu353/Arg394 and between its 40-hydroxyl and His524
(Fig. 7C, Table 2).
Crystallographic data have shown that the binding of
genistein into the ligand-binding site of the LBD of ERb
occursinasimilar modeasthatforERa,withthe7-hydroxylof
genistein forming hydrogen bondswith the amino acid residue
His475 and the 40-hydroxyl of genistein hydrogen bonding to
Glu305andArg346(Manasetal.2004).Docking ofthesethree
phytoestrogens into the LBD of ERb showed that all the
compounds bound with similarorientations tothose shownfor
ERa, with daidzein preferring the opposite orientation
compared with genistein and equol (data not shown).
MIFs, as calculated by GRID, have been used to indicate
favourable interactions between a probe and a target molecule
and have been used to inform structure-based drug design
(von Itzstein et al. 1993). Using GRID to calculate the energy
of interaction between a sulphoxide probe (OS) and the
ligand-binding siteofthe LBDofERaandERbindicatedthe
most favourable site in each case (lowest energy at K7.56 and
K6.43 kcal/mol for ERa and ERb respectively) was within
hydrogen-bondingcontact ofthe twokeyresidues involved in
ligand binding, namely Glu353(ERa)/Glu305(ERb) and
Arg394(ERa)/Arg346(ERb) (data not shown).
Discussion
Theoestrogenagonistpropertiesofthemonosulphatedformsof
genistein, daidzein and equol have been compared with those
of the aglycones in terms of their relative ability to compete
with [
3H]oestradiol for binding to ER, to induce a stably
transfected oestrogen-responsive reporter gene (ERE-CAT) in
MCF-7 cells and to stimulate growth of oestrogen-dependent
MCF-7 cells. The oestrogen agonist activities of genistein and
equolwerefoundtobeconsiderablygreaterthanfordaidzein,as
previously published (Matsumura et al. 2005). All the three
Table 2 Summary of the polar contacts and van der Waals interactions between the phytoestrogens genistein, daidzein and equol and the
residues in the binding site of the LBD of ERa. The genistein-ERa crystal structure (1!7R) is shown for reference. Interactions of the 7-
hydroxyl are shown in bold and those of the 40-hydroxyl in normal print.
Distance (A ˚)
Docked energy
a
(kcal/mol)
Hydroxyl
group GLU353 OE1 GLU353 OE2 ARG394 NH2 HIS524 ND1
Number of van der
Waals interactions
Compound
1!7R 72 .55 39
40 2.57 – 2.93
Genistein
b K16.38 72 .90 42
40 2.81 2.95 2.97
Genistein K15.73 7 – 2.85 2.92 47
40 2.78
Equol
b K17.60 72 .83 48
40 2.98 3.03 3.15
Equol K16.70 7 – 3.08 3.20 47
40 2.82
Daidzein
b K14.91 72 .81 2.83 2.78 41
40 2.70
Daidzein K11.97 72 .65 48
40 ––2 .45
‘–’ Indicates no polar contact.
aDocked energy is calculated as EZELJCEHBCEDRY.
bIndicates preferred binding mode (i.e. the pose exhibiting the lowest docked energy) as calculated by GRID/GLUE.
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based assays but genistein and equol gave responses at
consistently lower concentrations in all assays compared with
daidzein (Table 1). Sulphation resulted in markedly varied
alterations to the oestrogen agonist responses of these three
phytoestrogens, most notably in relation to the position of
sulphation and to the parent compound. In no case did
sulphation completely abolish all activity, which demonstrates
that monosulphation cannot be assumed to result in complete
abrogation of oestrogenic activity. However, the position of the
sulphation did inﬂuence in markedly different ways the
oestrogen agonist responses and did so rather differently for
daidzeincomparedwithgenisteinandequol.The40-sulphation
of genistein reduced oestrogen agonist activity to only a small
extentinthewhole-cell assays butactuallyincreased therelative
binding afﬁnity to ER (Table 1). By contrast, 7-sulphation of
genisteinreducedoestrogenagonistactivityverysubstantiallyin
allassays such that its rankorder in Table1 dropped from top to
almostbottom.The7-sulphationofequolresultedsimilarlyina
markedly reduced oestrogenic activity in all assays and a parallel
dramatic drop in rank order in Table 1 from almost top to the
bottom. By contrast, however, the position of monosulphation
of daidzein acted in an opposing manner on oestrogen agonist
activity. Sulphation at the 40-position of daidzein resulted in a
modestreductioninoestrogenagonistactivitybutincontrastto
eithergenisteinorequol,sulphationofdaidzeinatthe7-position
resultedinanincreaseinoestrogenagonistactivityandinarisein
ranking position in Table 1 compared with the aglycone.
Enhanced oestrogenicpotencyof a monosulphate relative to
theaglyconecanbeassumedtoresultfromanintrinsicproperty
of the monosulphated phytoestrogen. However, reduced levels
ofoestrogenic activityassociated withthemonosulphates could
have resulted not only from any intrinsic low oestrogenic
properties of the monosulphated phytoestrogen itself, but also
frompartialdesulphationofthephytoestrogensuchthatthelow
activity might have resulted from a mixture of inactive
monosulphate and small amounts of active desulphated
aglycone. MCF-7 cells are known to possess sulphatase activity
(Harris et al. 2004) and so enzymatic desulphation could have
occurred within the whole-cell assays. High-speed centri-
fugationoftheMCF-7celllysateswouldhavebeenexpectedto
at least reduce the sulphatase activity present in the MCF-7
cytosolic ER-binding assayand yet oestrogenic activitywas still
observed for all the monosulphates tested (Table 1). However,
the ﬁnding of continued weak ER-binding activity for
genstein-7-sulphate, equol-7-sulphate and daidzein-40-sul-
phate even when using puriﬁed recombinant human ERa,
where sulphatase activity could not have been present, suggests
thattheweakoestrogenicactivityisindeedagenuinepropertyof
the monosulphated phytoestrogen and is not an artefact of the
assay following enzymatic desulphation.
Oneexplanationfor theopposingeffectsof7-sulphationon
daidzein compared with genistein or equol could relate to
the mode in which these three phytoestrogens bind into the
LBD of the ER. Crystallographic studies have shown that
genistein binds into the ligand-binding site of either ERa or
ERb (Manas et al. 2004) by hydrogen bonding of its 40-
hydroxyl to Glu353(ERa)/Glu305(ERb) and Arg394(ERa)/
Arg346(ERb) and of its 7-hydroxyl to His524(ERa)/
His475(ERb), which is analogous to that with the binding of
17b-oestradiol through its 3- and 17-hydroxyls respectively
(Brzozowski et al. 1997; illustrated in Fig. 1). The molecular
modelling and docking studies presented here suggest that
equolcanbindintotheLBDofeitherERaorERbinasimilar
manner to that of genistein but that the lowest energy
conformation for the binding of daidzein is in the opposite
orientation.Furthermore,theGRIDcalculationperformedin
thiswork,toﬁndapotentialsulphationsiteintheregionofthe
ligand-binding site, indicates that the most energetically
favourable location places a sulphoxide moiety within
hydrogen-bonding distance of Glu353 and Arg394 (Glu305
and Arg346 ERb). Together, these results would then suggest
that sulphation of the hydroxyl group which hydrogen bonds
tothehistidineresidue524ofERaor475ofERbresultsinloss
of oestrogen agonist activity whilst sulphation of the hydroxyl
group within hydrogen-bonding distance to Glu353(ERa)/
Glu305(ERb) and Arg394(ERa)/Arg346(ERb) can result in
increased oestrogen agonist activity.
Although the 40-and7-hydroxylgroupsofthesephytoestro-
gens form important hydrogen bonds with amino acids in the
LBD, this work demonstrates that other components of the
ligandstructure alsoplaya key role. Daidzeindiffers fromequol
onlybythepresenceofacarbonylgroupandfromgenisteinonly
by the lack of a hydroxyl group adjacent to the carbonyl group
(Fig.1).However,thisdifferenceinchemicalstructureresultsin
markeddifferencestosubsequentbiologicalactivityoftheligand
and its metabolites. Previous work has shown that not only 40-
sulphationofgenisteincandecreaseitsabilitytoincreasegrowth
of oestrogen-responsive MCF-7 cells (Kinjo et al. 2004), in
agreementwithresultshere,butcanalsodecreaseitsantioxidant
activity(Turneretal.2004)anditseffectonplateletaggregation,
inﬂammation, cell adhesion and chemotaxis (Rimbach et al.
2004). However, no previous work has reported any potential
neither for enhanced activity of an isoﬂavone following
sulphation nor for inverse alterations between individual
phytoestrogens. Since other phytoestrogens (Woods 2003) and
also xenoestrogens (Sacco & James 2005) are subject to
sulphation, it will now be important to investigate the effects
ofsulphateconjugationonawider rangeofoestrogenicligands.
The effects in these assays in vitro were observed at
concentrations which were not incompatible with expected
exposureinvivofollowingconsumptionofsoyafoods.Thelevels
of genistein in adult plasma following soya consumption have
been reported in the range of 1–8 mM (Woods 2003). Mean
plasma concentrations of genistein and daidzein in infants fed
soya-based formulae have been reported to be 684 ng/ml
(equivalent to 2.5 mM) and 295 ng/ml (equivalent to 1.2 mM)
respectively (Setchell et al. 1997). Assuming about 20% of each
phytoestrogen would be present as a monosulphate (see
Introduction), this would equate to an exposure in vivo in
infantsfedsoyafoodsof0.5and0.25 mMforthemonosulphates
of genistein and daidzein respectively. The IC50 values for
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MCF-7 cell-based assay used here (Table 1). IC50 values for
daidzein-7-sulphatewerebelowthisvalueforcellgrowthassays
(Table1),andmeasurableeffectswerefoundinthereportergene
assay albeit below the IC50 value (Fig. 3). In terms of breast
exposure speciﬁcally, after soya consumption, nipple aspirate
ﬂuid has been reported to contain large amounts of
unconjugated genistein, moderate the amounts of sulphated
genistein and hardly any glucuronide compared with blood of
the same patient which contained mostly genistein
b-glucuronide (Peterson et al. 1998). This suggests that
sulphation may be a major form of conjugation within the
humanbreast,whichisnotablyanoestrogen-sensitivetissueand
is the target for the development of oestrogen-responsive
cancers(Miller1996).Theresultsheredemonstrateoestrogenic
actions of sulphated genistein and daidzein in MCF-7 human
breast cancer cells that contain predominantly ERa (Shaw et al.
2006)and thereforeemphasise that sulphateconjugates must be
considered as a source of biologically active ligand for breast
cancercells. Whether thelevelofERb within the breast cancer
cells might inﬂuence the overall activity remains to be
determined. Genistein, daidzein and equol have all been
shown to more strongly bind to ERb than to ERa (Hwang
et al. 2006), and daidzein-7-sulphate has been shown to be able
to transactivate reporter gene expression in ERb-transfected
HeLa cells (Totta et al. 2005). These ﬁndings highlight the
complexityof the effects of sulphation on the overall biological
activity of phytoestrogens but demonstrate the need to take
variationsinconjugationintoaccountbothbetweenindividuals
and between tissues when assessing potential health beneﬁts of
soya isoﬂavone consumption.
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